177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer

NCT05613738 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: 1.11 GBq (30 mCi) of 177Lu-PSMA-EB-01
DRUG: 1.85 GBq (50 mCi) of 177Lu-PSMA-EB-01
DRUG: 2.59 GBq (70 mCi) of 177Lu-PSMA-EB-01

Sponsor

Peking Union Medical College Hospital